BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29467575)

  • 1. Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.
    Wang F; Pang JD; Huang LL; Wang R; Li D; Sun K; Wang LT; Zhang LM
    Int J Nanomedicine; 2018; 13():857-875. PubMed ID: 29467575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of siAEG-1 and doxorubicin to treat osteosarcoma via nanomicelles for azide-alkyne "click" conjugation of poly(l-lysine) dendrons onto Zein.
    Pang J; Huang L; Lian Y; Yuan Z; Wang F; Zhang LM
    Int J Biol Macromol; 2024 Apr; 264(Pt 2):130729. PubMed ID: 38460643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.
    Liu T; Wu X; Wang Y; Zhang T; Wu T; Liu F; Wang W; Jiang G; Xie M
    Oncotarget; 2016 Jul; 7(27):42017-42030. PubMed ID: 27259274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
    Rajasekaran D; Srivastava J; Ebeid K; Gredler R; Akiel M; Jariwala N; Robertson CL; Shen XN; Siddiq A; Fisher PB; Salem AK; Sarkar D
    Bioconjug Chem; 2015 Aug; 26(8):1651-61. PubMed ID: 26079152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy.
    Zhou X; Zheng Q; Wang C; Xu J; Wu JP; Kirk TB; Ma D; Xue W
    ACS Appl Mater Interfaces; 2016 May; 8(20):12609-19. PubMed ID: 27153187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of VEGF-siRNA mediated by adenovirus on osteosarcoma-bearing nude mice.
    Gao YS; Mei J; Tong TL; Hu M; Xue HM; Cai XS
    Cancer Biother Radiopharm; 2009 Apr; 24(2):243-7. PubMed ID: 19409047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis.
    Wang F; Ke ZF; Sun SJ; Chen WF; Yang SC; Li SH; Mao XP; Wang LT
    Cancer Biol Ther; 2011 Sep; 12(6):539-48. PubMed ID: 21750404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable supramolecular hydrogel formed from α-cyclodextrin and PEGylated arginine-functionalized poly(l-lysine) dendron for sustained MMP-9 shRNA plasmid delivery.
    Lin Q; Yang Y; Hu Q; Guo Z; Liu T; Xu J; Wu J; Kirk TB; Ma D; Xue W
    Acta Biomater; 2017 Feb; 49():456-471. PubMed ID: 27915016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway.
    Wang Z; Cao CJ; Huang LL; Ke ZF; Luo CJ; Lin ZW; Wang F; Zhang YQ; Wang LT
    Oncotarget; 2015 Jun; 6(16):14191-208. PubMed ID: 25987128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated small interfering RNA targeting ezrin induces apoptosis and inhibits metastasis of human osteosarcoma MG-63 cells.
    Tao ZW; Zou PA
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29899165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma.
    Hirahata M; Osaki M; Kanda Y; Sugimoto Y; Yoshioka Y; Kosaka N; Takeshita F; Fujiwara T; Kawai A; Ito H; Ochiya T; Okada F
    Cancer Med; 2016 May; 5(5):892-902. PubMed ID: 26817521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
    Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
    Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-342-3p Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting Astrocyte-Elevated Gene-1 (AEG-1).
    Zhang S; Liu L; Lv Z; Li Q; Gong W; Wu H
    Oncol Res; 2017 Nov; 25(9):1505-1515. PubMed ID: 28276315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin-functionalized chitosan-graft-poly(l-lysine) dendrons as a high-efficiency gene delivery carrier for nasopharyngeal carcinoma therapy.
    Liu T; Chen S; Zhang S; Wu X; Wu P; Miao B; Cai X
    J Mater Chem B; 2018 Jul; 6(26):4314-4325. PubMed ID: 32254507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-loaded poly(histidine-arginine)
    Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
    Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.